2/23
11:06 pm
nerv
Minerva Neurosciences, Inc. (NASDAQ: NERV) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Minerva Neurosciences, Inc. (NASDAQ: NERV) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
2/22
07:02 am
nerv
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates [Yahoo! Finance]
High
Report
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates [Yahoo! Finance]
2/22
07:00 am
nerv
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates
High
Report
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates
2/12
10:05 pm
nerv
Minerva Neurosciences, Inc. (NASDAQ: NERV) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Minerva Neurosciences, Inc. (NASDAQ: NERV) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
2/2
01:05 am
nerv
Minerva Neurosciences, Inc. (NASDAQ: NERV) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Minerva Neurosciences, Inc. (NASDAQ: NERV) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
1/25
10:34 pm
nerv
Minerva Neurosciences, Inc. (NASDAQ: NERV) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
Minerva Neurosciences, Inc. (NASDAQ: NERV) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.